These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
87 related articles for article (PubMed ID: 4922588)
1. [Evaluation of potassium exchange in myasthenia gravis and some other neurological diseases]. Rowińska K; Kapuściński A Neurol Neurochir Pol; 1970; 4(6):633-9. PubMed ID: 4922588 [No Abstract] [Full Text] [Related]
2. Assessment of exchangeable potassium in myasthenia and in certain other neurological diseases. Rowińska K; Kapuściński A Pol Med J; 1971; 10(3):750-6. PubMed ID: 4941886 [No Abstract] [Full Text] [Related]
3. [Discussion on the "fine structure of the targetoid fibers of the extraocular muscles in myasthenia"]. Mukuno K Shinkei Kenkyu No Shimpo; 1971; 15(4):850-3. PubMed ID: 4400829 [No Abstract] [Full Text] [Related]
4. [A study of periodic paralysis, episodic paralysis and myotonic dystrophy]. Schwartzkopff W; Ulbricht W; Quabbe HJ Z Neurol; 1971; 200(1):80-97. PubMed ID: 4108149 [No Abstract] [Full Text] [Related]
5. The myotonic disorders and the periodic paralyses. Griggs RC Adv Neurol; 1977; 17():143-59. PubMed ID: 888733 [No Abstract] [Full Text] [Related]
6. STUDIES IN NEUROMUSCULAR DISEASE. I. TOTAL BODY POTASSIUM IN MUSCULAR DYSTROPHY AND RELATED DISEASES. KOSSMANN RJ; PETERSON DC; ANDREWS HL Neurology; 1965 Sep; 15():855-65. PubMed ID: 14334962 [No Abstract] [Full Text] [Related]
7. Biochemistry of striated muscle during human muscular diseases. Schapira G; Dreyfus JC; Schapira F Enzymol Biol Clin (Basel); 1970; 11(1):8-31. PubMed ID: 4905517 [No Abstract] [Full Text] [Related]
8. Familial periodic paralysis: low muscle potassium permeability or high sodium permeability? Schipperheyn JJ; Buruma OJ Ann Neurol; 1983 Jun; 13(6):686. PubMed ID: 6881933 [No Abstract] [Full Text] [Related]
9. [2 cases of myasthenia gravis with outstanding effects of massive potassium treatment--evaluation of potassium metabolism]. Yoshikawa N; Noguchi S; Iguchi H; Morimune S; Nishitani H Nihon Rinsho; 1973 Feb; 31(2):401-3. PubMed ID: 4737130 [No Abstract] [Full Text] [Related]
10. Diagnosis and treatment of muscle diseases. Merritt HH Med Times; 1977 Aug; 105(8):35-44. PubMed ID: 886940 [No Abstract] [Full Text] [Related]
11. Muscle diseases relevant to the anesthetist. Lehmann-Horn F; Knorr-Held S Acta Anaesthesiol Belg; 1990; 41(2):113-8. PubMed ID: 2196753 [No Abstract] [Full Text] [Related]
12. Research trends pertinent to the management of neuromuscular diseases. Moxley RT Adv Neurol; 1977; 17():13-24. PubMed ID: 70158 [No Abstract] [Full Text] [Related]
13. MUSCLE DISORDERS AND THE RELAXANTS. WISE RP Br J Anaesth; 1963 Sep; 35():558-64. PubMed ID: 14066107 [No Abstract] [Full Text] [Related]
19. The effect of aldactone-A on intracellular potassium in patients with myasthenia gravis. Oosterhuis HJ; van der Slooten EP J Neurol Sci; 1973 Aug; 19(4):453-60. PubMed ID: 4579659 [No Abstract] [Full Text] [Related]
20. Potassium metabolism in myasthenia gravis. Ozdemir C; Hatemi H; Ozturk EO Dis Nerv Syst; 1968 Dec; 29(12):834-6. PubMed ID: 5717297 [No Abstract] [Full Text] [Related] [Next] [New Search]